Santen earnings date is November 5, 2026: Santen stock gains 2.88 percent

Published on 10/15/2026 at 19:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached JPY 68.96 billion on August 6, 2026. Santen stock costs EUR 9.73 on October 15, 2026, up 2.88 percent on Tokyo Stock Exchange.

Upcoming earnings and valuation

Santen's next earnings date is November 5, 2026, according to Yahoo Finance.
Second-quarter revenue reached JPY 68.96 billion on August 6, 2026, up 0.30 percent year over year.
Santen stock costs EUR 9.73 at Lang & Schwarz on October 15, 2026 at 7:03 p.m. CEST; the Tokyo Stock Exchange listing rose 2.88 percent versus its prior close.
Santen had a market capitalization of JPY 550.2 billion and a P/E ratio of 14.41 as of October 15, 2026.

Santen, JP3336000009, Illustration mit AI erstellt.

Santen's next earnings date is November 5, 2026, according to Yahoo Finance. Santen stock was last at EUR 9.73 at Lang & Schwarz on October 15, 2026 at 7:03 p.m. CEST, while the Tokyo Stock Exchange listing rose 2.88 percent on the day.

Revenue reached JPY 68.96 billion

Santen's second-quarter revenue reached JPY 68.96 billion on August 6, 2026, up 0.30 percent from the corresponding period a year earlier, according to JPX Market Explorer. Net income reached JPY 7.19 billion, while earnings per share rose 29.10 percent year over year. The same report put the EBITDA margin at 18.61 percent, compared with 17.56 percent a year earlier.

Stock stays inside its range

The Tokyo Stock Exchange listing was last at JPY 1,712.50 on October 15, 2026 at 3:30 p.m. JST, versus a prior close of JPY 1,664.50. The 52-week range was JPY 1,458.00 to JPY 2,254.00. Lang & Schwarz showed a bid of EUR 9.55 and an ask of EUR 9.90, while volume on the Tokyo Stock Exchange reached 1,315,500 shares against an average of 1,258,215.

Valuation and the next date

Santen had a market capitalization of JPY 550.2 billion and a P/E ratio of 14.41 as of October 15, 2026. The company operates in healthcare and pharmaceuticals, with ophthalmic medicines and devices at the center of its business. The November 5, 2026 earnings date gives investors the next fixed checkpoint after the second-quarter figures.

Comparison with peers

Santen: plus 2.88 percent, P/E 14.41, market capitalization JPY 550.2 billion

Rohto (Tokyo Stock Exchange, JPY): plus 2.58 percent, P/E 20.68, market capitalization JPY 656.0 billion

Sumitomo Pharma (Tokyo Stock Exchange, JPY): plus 15.81 percent, P/E 6.58, market capitalization JPY 826.3 billion

Price and investor perspective

Santen's operating picture combines modest revenue growth with faster earnings-per-share growth in the second quarter. The valuation sits below Rohto's P/E ratio but above Sumitomo Pharma's, while the upcoming November 5 reporting date provides the next company-specific test.

Santen stock was trading at EUR 9.73 at Lang & Schwarz on October 15, 2026 at 7:03 p.m. CEST. On the Tokyo Stock Exchange, the stock was last at JPY 1,712.50 on October 15, 2026 at 3:30 p.m. JST, up 2.88 percent versus JPY 1,664.50.

The further course of trading is shown by the continuously updated real-time quote of Santen stock.